New insights into the structural elements involved in the skin haemorrhage induced by snake venom metalloproteinases

Summary

Haemorrhage induced by snake venom metalloproteinases (SVMPs) is a complex phenomenon resulting in capillary disruption and extravasation. This study analysed structural elements important for the interaction of four Bothrops jararaca SVMPs of different domain organisation and glycosylation levels with plasma and extracellular matrix proteins: HF3 (P-III class) is highly glycosylated and ~80 times more haemorrhagic than bothropasin (P-III class), which has a minor carbohydrate moiety; BJ-PI (P-I class) is not haemorrhagic and the DC protein is composed of disintegrin-like/cysteine-rich domains of bothropasin. HF3, bothropasin and BJ-PI showed different degradation profiles of fibrinogen, fibronectin, vitronectin, von Willebrand factor, collagens IV and VI, laminin and Matrigel™; however, only bothropasin degraded collagen I. In solid-phase binding assays HF3 and bothropasin interacted with fibrinogen, fibronectin, laminin, collagens I and VI; the DC protein bound only to collagens I and VI; however, no binding of BJ-PI to these proteins was detected. N-deglycosylation caused loss of structural stability of bothropasin and BJ-PI but HF3 remained intact, although its haemorrhagic and fibrinogenolytic activities were partially impaired. Nevertheless, N-deglycosylated HF3 bound with higher affinity to collagens I and VI, although its proteolytic activity upon these collagens was not enhanced. This study demonstrates that features of carbohydrate moieties of haemorrhagic SVMPs may play a role in their interaction with substrates of the extracellular matrix, and the ability of SVMPs to degrade proteins in vitro does not correlate to their ability to cause haemorrhage, suggesting that novel, systemic approaches are necessary for understanding the mechanism of haemorrhage generation by SVMPs.

Keywords

Extracellular matrix - haemorrhage - metalloproteinase - proteolysis - snake venom

• References

• 1 Takahashi T, Ohsaka A. Purification and characterization of a proteinase in the venom of Trimeresurus flavoviridis. Complete separation of the enzyme from hemorrhagic activity.. Biochim Biophys Acta 1970; 198: 293-307.
• 2 Shannon JD, Baramova EN, Bjarnason JB. et al. Amino acid sequence of a Crotalus atrox venom metalloproteinase which cleaves type IV collagen and gelatin.. J Biol Chem 1989; 264: 11575-11583.
• 3 Rucavado A, Lomonte B, Ovadia M. et al. Local tissue damage induced by BaP1, a metalloproteinase isolated from Bothrops asper (Terciopelo) snake venom.. Exp Mol Pathol 1995; 63: 186-199.
• 4 Gutiérrez JM, Rucavado A, Escalante T. et al. Hemorrhage induced by snake venom metalloproteinases: biochemical and biophysical mechanisms involved in microvessel damage.. Toxicon 2005; 45: 997-1011.
• 5 Rucavado A, Soto M, Escalante T. et al. Thrombocytopenia and platelet hypo-aggregation induced by Bothrops asper snake venom. Toxins involved and their contribution to metalloproteinase-induced pulmonary hemorrhage.. Thromb Haemost 2005; 94: 123-131.
• 6 Wu WB, Peng HC, Huang TF. Crotalin, a vWF and GP Ib cleaving metalloproteinase from venom of Crotalus atrox.. Thromb Haemost 2001; 86: 1501-1511.
• 7 Wang WJ, Huang TF. Purification and characterization of a novel metalloproteinase, acurhagin, from Agkistrodon acutus venom.. Thromb Haemost 2002; 87: 641-650.
• 8 Fox JW, Serrano SM. Structural considerations of the snake venom metalloproteinases, key members of the M12 reprolysin family of metalloproteinases.. Toxicon 2005; 45: 969-985.
• 9 Laing GD, Moura-da-Silva AM. Jararhagin and its multiple effects on hemostasis.. Toxicon 2005; 45: 987-996.
• 10 Kamiguti AS. Platelets as targets of snake venom metalloproteinases.. Toxicon 2005; 45: 1041-1049.
• 11 Bjarnason JB, Fox JW. Snake venom metalloendopeptidases: reprolysins.. Methods Enzymol 1995; 248: 345-368.
• 12 Black RA, White JM. ADAMs: focus on the protease domain.. Curr Opin Cell Biol 1998; 10: 654-659.
• 13 Tang BL, Hong W. ADAMTS: a novel family of proteases with an ADAM protease domain and thrombospondin 1 repeats.. FEBS Lett 1999; 445: 223-225.
• 14 Fox JW, Serrano SM. Insights into and speculations about snake venom metalloproteinase (SVMP) synthesis, folding and disulfide bond formation and their contribution to venom complexity.. FEBS J 2008; 275: 3016-3030.
• 15 Kamiguti AS, Slupsky JR, Zuzel M. et al. Properties of fibrinogen cleaved by Jararhagin, a metalloproteinase from the venom of Bothrops jararaca.. Thromb Haemost 1994; 72: 244-249.
• 16 Hamako J, Matsui T, Nishida S. et al. Purification and characterization of kaouthiagin, a von Willebrand factor-binding and -cleaving metalloproteinase from Naja kaouthia cobra venom.. Thromb Haemost 1998; 80: 499-505.
• 17 Serrano SM, Wang D, Shannon JD. et al. Interaction of the cysteine-rich domain of snake venom metalloproteinases with the A1 domain of von Willebrand factor promotes site-specific proteolysis of von Willebrand factor and inhibition of von Willebrand factor-mediated platelet aggregation.. FEBS J 2007; 274: 3611-3621.
• 18 Baldo C, Tanjoni I, León IR. et al. BnP1, a novel P-I metalloproteinase from Bothrops neuwiedi venom: biological effects benchmarking relatively to jararhagin, a P-III SVMP.. Toxicon 2008; 51: 54-65.
• 19 White JM. ADAMs: modulators of cell-cell and cell-matrix interactions.. Curr Opin Cell Biol 2003; 15: 598-606.
• 20 Porter S, Clark IM, Kevorkian L. et al. The ADAMTS metalloproteinases.. Biochem J 2005; 386: 15-27.
• 21 Seals DF, Courtneidge SA. The ADAMs family of metalloproteases: multidomain proteins with multiple functions.. Genes Dev 2003; 17: 7-30.
• 22 Luken BM, Turenhout EA, Hulstein JJ. et al. The spacer domain of ADAMTS13 contains a major binding site for antibodies in patients with thrombotic thrombocytopenic purpura.. Thromb Haemost 2005; 93: 267-274.
• 23 Gerhardt S, Hassall G, Hawtin P. et al. Crystal structures of human ADAMTS1 reveal a conserved catalytic domain and a disintegrin-like domain with a fold homologous to cysteine-rich domains.. J Mol Biol 2007; 373: 891-902.
• 24 Groot R, Bardhan A, Ramroop N. et al. Essential role of the disintegrin-like domain in ADAMTS13 function.. Blood 2009; 113: 5609-5616.
• 25 Serrano SM, Jia LG, Wang D. et al. Function of the cysteine-rich domain of the haemorrhagic metalloproteinase atrolysin A: targeting adhesion proteins collagen I and von Willebrand factor.. Biochem J 2005; 391: 69-76.
• 26 Serrano SM, Kim J, Wang D. et al. The cysteine-rich domain of snake venom metalloproteinases is a ligand for von Willebrand factor A domains: role in substrate targeting.. J Biol Chem 2006; 281: 39746-39756.
• 27 Menezes MC, Paes Leme AF, Melo RL. et al. Activation of leukocyte rolling by the cysteine-rich domain and the hyper-variable region of HF3, a snake venom hemorrhagic metalloproteinase.. FEBS Lett 2008; 582: 3915-3921.
• 28 Assakura MT, Reichl AP, Mandelbaum FR. Comparison of immunological, biochemical and biophysical properties of three hemorrhagic factors isolated from the venom of Bothrops jararaca (jararaca).. Toxicon 1986; 24: 943-946.
• 29 Silva CA, Zuliani JP, Assakura MT. et al. Activation of alpha(M)beta(2)-mediated phagocytosis by HF3, a P-III class metalloproteinase isolated from the venom of Bothrops jararaca. Biochem.. Biophys Res Commun 2004; 322: 950-956.
• 30 Mandelbaum FR, Reichel AP, Assakura MT. Isolation and characterization of a proteolytic enzyme from the venom of the snake Bothrops jararaca (Jararaca).. Toxicon 1982; 20: 955-972.
• 31 Assakura MT, Silva CA, Mentele R. et al. Molecular cloning and expression of structural domains of bothropasin, a P-III metalloproteinase from the venom of Bothrops jararaca.. Toxicon 2003; 41: 217-227.
• 32 Oliveira AK, Paes Leme AF, Assakura MT. et al. Simplified procedures for the isolation of HF3, bothropasin, disintegrin-like/cysteine-rich protein and a novel P-I metalloproteinase from Bothrops jararaca venom.. Toxicon 2009; 53: 797-801.
• 33 Usami Y, Fujimura Y, Miura S. et al. A 28 kDa-protein with disintegrin-like structure (jararhagin-C) purified from Bothrops jararaca venom inhibits collagen- and ADP-induced platelet aggregation.. Biochem Biophys Res Commun 1994; 201: 331-339.
• 34 Moura-da-Silva AM, Della-Casa MS, David AS. et al. Evidence for heterogeneous forms of the snake venom metalloproteinase jararhagin: a factor contributing to snake venom variability.. Arch Biochem Biophys 2003; 409: 395-401.
• 35 Ohsaka A. Handbook of Experimental Pharmacology.. In: Snake Venoms.. Lee C.Y.. (Ed.) Springer-Verlag; Berlin: 1979: 480-546.
• 36 Kamiguti AS, Hay CRM, Theakston RDG. et al. Insights into the mechanism of haemorrhage caused by snake venom metalloproteinases.. Toxicon 1996; 34: 627-642.
• 37 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.. Nature 1970; 227: 680-685.
• 38 Steel LF, Trotter MG, Nakajima PB. et al. Efficient and specific removal of albumin from human serum samples.. Mol Cell Proteomics 2003; 2: 262-270.
• 39 Burnette WN. Western blotting: electrophoretic transfer of proteins from sodium dodecyl sulfate–polyacrylamide gels to unmodified nitrocellulose and radio-graphic detection with antibody and radioiodinated protein A.. Anal Biochem 1981; 112: 195-203.
• 40 Paes Leme AF, Prezoto BC, Yamashiro ET. et al. Bothrops protease A, a unique highly glycosylated serine proteinase, is a potent, specific fibrinogenolytic agent.. J Thromb Haemost 2008; 6: 1363-1372.
• 41 Baramova EN, Shannon JD, Bjarnason JB. et al. Degradation of extracellular matrix proteins by hemorrhagic metalloproteinases.. Arch Biochem Biophys 1989; 275: 63-71.
• 42 Escalante T, Shannon J, Moura-da-Silva AM. et al. Novel insights into capillary vessel basement membrane damage by snake venom hemorrhagic metalloproteinases: a biochemical and immunohistochemical study.. Arch Biochem Biophys 2006; 455: 144-153.
• 43 Makogonenko E, Tsurupa G, Ingham K. et al. Interaction of fibrin(ogen) with fibronectin: further characterization and localization of the fibronectin-binding site.. Biochemistry 2002; 41: 7907-7913.
• 44 Preissner KT, Holzhüter S, Justus C. et al. Identification of and partial characterization of platelet vitronectin: evidence for complex formation with platelet-derived plasminogen activator inhibitor-1.. Blood 1989; 74: 1989-1996.
• 45 Corbett SA, Lee L, Wilson CL. et al. Covalent cross-linking of fibronectin to fibrin is required for maximal cell adhesion to a fibronectin-fibrin matrix.. J Biol Chem 1997; 272: 24999-25005.
• 46 Podor TJ, Campbell S, Chindemi P. et al. Incorporation of vitronectin into fibrin clots. Evidence for a binding interaction between vitronectin and gamma A/gamma’ fibrinogen.. J Biol Chem 2002; 277: 7520-7528.
• 47 Tseng YL, Wu WB, Hsu CC. et al. Inhibitory effects of human alpha2-macroglobulin and mouse serum on the PSGL-1 and glycoprotein Ib proteolysis by a snake venom metalloproteinase, triflamp.. Toxicon 2004; 43: 769-777.
• 48 Escalante T, Rucavado A, Kamiguti AS. et al. Bothrops asper metalloproteinase BaP1 is inhibited by alpha(2)-macroglobulin and mouse serum and does not induce systemic hemorrhage or coagulopathy.. Toxicon 2004; 43: 213-217.
• 49 Baramova EN, Shannon JD, Bjarnason JB. et al. Interaction of hemorrhagic metalloproteinases with human a2-macroglobulin.. Biochemistry 1990; 29: 1069-1074.
• 50 Tanjoni I, Evangelista K, Della-Casa MS. et al. Different regions of the class P-III snake venom metalloproteinase jararhagin are involved in binding to alpha(2)beta(1) integrin and collagen.. Toxicon. 2010 Epub ahead of print.
• 51 Moura-da-Silva AM, Ramos OH, Baldo C. et al. Collagen binding is a key factor for the hemorrhagic activity of snake venom metalloproteinases.. Biochimie 2008; 90: 484-492.
• 52 Gowda DC, Jackson CM, Kurzban GP. et al. Core sugar residues of the N-linked oligosaccharides of Russell’s viper venom factor X-activator maintain functionally active polypeptide structure.. Biochemistry 1996; 35: 5833-5837.
• 53 Chen HS, Chen JM, Lin CW. et al. New insights into the functions and N-glycan structures of factor X activator from Russell’s viper venom.. FEBS J 2008; 275: 3944-3958.